Category: 35 U.S.C. § 102

Federal Circuit Clarifies Post-America Invents Act “On-Sale” Bar Based on Publicly Announced Sale Agreements: Invalidates Four Anti-Nausea Drug Patents

by iplitblog | May 3, 2017

By Michelle Alamo On May 1st, the Federal Circuit ruled that the America Invents Act (AIA) did not change the statutory meaning of “on sale” where the existence of a sale was publicly announced prior to patenting, even if...

Newsletter Subscription

<a href="https://marketing.dickinson-wright.com/s/9082d74912ba952a02e2e01fa17c1fbca62ab6a4">View Survey</a>

Disclaimer

IP Litigation Blog is published by Dickinson Wright PLLC to inform the public of important developments within the firm and practice areas. The content is informational only and does not constitute legal or professional advice. We encourage you to consult a Dickinson Wright attorney if you have specific questions or concerns relating to any of the topics covered in this blog.

Category: 35 U.S.C. § 102

Federal Circuit Clarifies Post-America Invents Act “On-Sale” Bar Based on Publicly Announced Sale Agreements: Invalidates Four Anti-Nausea Drug Patents

Newsletter Subscription

Disclaimer

Categories